SUBSCRIBE
SUBSCRIBE
News   Drug Development

Johnson & Johnson Strengthens Warning on HIV Drug

August 27, 2009 | 
1 min read
Bookmark and Share

Reuters -- Johnson & Johnson has strengthened a warning about serious skin reactions in patients treated with the company's HIV drug Intelence, U.S. regulators and the company said on Wednesday.
Clinical research Postmarket research
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
Opportunity of winning. man sees a illuminated trophy door. vector
autoimmune disease
Amgen asset from $27.8B Horizon buy scores in Phase 3 Sjögren’s study
September 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Human kidney made out of lines. Medical Concept. 3D Rendering.
Kidney disease
Roche-Ionis’ RNA therapy reduces kidney disease marker, opening path to swift FDA nod
September 23, 2026
 · 
2 min read
 · 
Annalee Armstrong
Microscope icon. Molecule and communication background. Connected lines with dots.
Deals
Novartis bets up to $900M for radioligand therapy from China’s BoomRay
September 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Close up shot red darts arrows in the target center on dark blue sky background. Business target or goal success and winner concept.
ALS
Ionis-Otsuka offer ‘groundbreaking’ improvement in function and survival for genetic type of ALS
September 23, 2026
 · 
4 min read
 · 
Heather McKenzie